For Terminally Ill In California, End Of Suffering Is Now In Sight
Terminal patients and doctors prepare themselves for California’s new assisted suicide law, which takes effect June 9.
Cancer
221 - 229 of 229 Results
-
-
Insurer’s Approval Of Genetic Testing For Some Cancers Raises Questions
The decision by Independence Blue Cross of Pennsylvania to pay for whole genome sequencing for some cancer patients adds to the debate about how to handle these expensive tests.
-
Consumer And Research Groups Release Cancer Guides For Patients
Families USA and the Institute for Clinical and Economic Review are collaborating on a series of patient guides on treatment and screenings.
-
Heavy Use Of CT Scans Raises Concerns About Patients’ Exposure To Radiation
CT scans, which are administered more than 85 million times a year, are an important diagnostic tool, but just one can be equivalent to 200 X-rays. Some doctors warn that health providers are not considering possible consequences when ordering the tests.
-
More Employers Offer Plans That Provide Lump Sums For Critical Illnesses
The plans can help workers cover their high deductibles, but the policies also have limitations.
-
Medicare Payment Changes Lead More Men To Get Screening Colonoscopies
The health law waived Medicare’s Part B deductible and dropped the 20 percent copayment for the preventive tests.
-
Health Plans’ Coverage Of Some Drugs Can Be A Source Of Consumer Confusion
Some medicines, particularly intravenous treatments, are not listed in plans’ pharmacy benefit section and, therefore, it’s difficult to confirm coverage specifics.
-
Cancer Meds Often Bring Big Out-Of-Pocket Costs For Patients, Report Finds
The advocacy arm of the American Cancer Society said Wednesday that federal and state governments should move to restrict insurers from charging patients a percentage of the cost of their prescription drugs.
-
Calif. Medicaid Patients With Cancer Fare Worse Than Those With Other Coverage
Researchers found Medi-Cal patients were diagnosed later, were less likely to receive recommended treatment and had lower survival rates.
Ìý